Study of Roflumilast in Combination With Standard Chemotherapy for High-risk Diffuse Large B-cell Lymphoma
Clinical trial NCT03458546 · COMPLETED
Trial details
- NCT number
- NCT03458546
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2021-12-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.